About Baader Schulz Laboratories Private Limited
Data last updated:
Baader Schulz Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2021PTC362976. Its GSTIN is 27AAJCB9457E1ZD (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Neela Nailesh Shah and Nailesh Kirtilal Shah.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹95.24 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹2.01 Cr (net margin 2.1%) and EBITDA of ₹7.14 Cr (EBITDA margin 7.5%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years.
As per MCA filings, the company has open charges of ₹31.2 Cr and satisfied charges of ₹34.78 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website baaderschulz.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address1501 Friends Business Bay, L.T. Road Borivali, Mumbai, Maharashtra, India – 400092
- IndustryPharma, Drug Formulation & Development, Animal Pharmaceuticals & Healthcare
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Baader Schulz Laboratories Private Limited
The main business activity of Baader Schulz Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Baader Schulz Laboratories Private Limited FY 2024 filings available
Baader Schulz Laboratories Private Limited reported revenue of ₹95.24 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Baader Schulz Laboratories Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 6% over three years, including 9% growth in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Baader Schulz Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.14 Cr | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.01 Cr | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Baader Schulz Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 7.5% | •••• | •••• | •••• |
| Net Profit Margin | 2.1% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Baader Schulz Laboratories are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Baader Schulz Laboratories Private Limited
Baader Schulz Laboratories Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Animal Pharma). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ayurvet Limited | ₹107.61 Cr (FY 2023) | •••• | •••• | 3.0% | •••• | Ahmedabad, Gujarat, India |
| Indovax Private Limited | ₹105 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | New Delhi, Delhi, India |
| Timo Eva Wellness Private Limited | ₹102.77 Cr (FY 2024) | •••• | •••• | 31.0% | •••• | Bangalore, Karnataka, India |
| Natural Herbs and Formulation Private Limited | ₹101.16 Cr (FY 2025) | •••• | •••• | 62.0% | •••• | Roorkee, Uttarakhand, India |
| Provet Pharma Private Limited | ₹100.73 Cr (FY 2025) | •••• | •••• | 35.0% | •••• | Chennai, Tamil Nadu, India |
| Baader Schulz Laboratories Private Limited this company | ₹95.24 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Mumbai, Maharashtra, India |
| Micro Animal Health Care Private Limited | ₹88.47 Cr (FY 2024) | •••• | •••• | 86.0% | •••• | Bangalore, Karnataka, India |
| Vetsfarma Limited | ₹85.2 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Jalandhar, Punjab, India |
| Vivaldis Health and Foods Private Limited | ₹81.41 Cr (FY 2025) | •••• | •••• | 34.0% | •••• | Pune, Maharashtra, India |
| Saife Vetmed Private Limited | ₹79.95 Cr (FY 2024) | •••• | •••• | 40.0% | •••• | Delhi, India |
| Vaksindo Animal Health Private Limited | ₹74.16 Cr (FY 2025) | •••• | •••• | 51.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Baader Schulz Laboratories by revenue in the Pharma industry (Animal Pharma), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Baader Schulz Laboratories Private Limited
Baader Schulz Laboratories Private Limited is audited by LATA RAMESH AND ASSOCIATES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| LATA RAMESH AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Baader Schulz Laboratories Private Limited
Baader Schulz Laboratories has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neela Nailesh Shah | Director | 29 Jun 2021 | 5 Years 3 Months | Current |
| Nailesh Kirtilal Shah | Director | 29 Jun 2021 | 5 Years 3 Months | Current |
Ownership and Shareholding of Baader Schulz Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Baader Schulz Laboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 May 2024 | Others | ₹24.1 Cr | Open |
| 16 Dec 2023 | Hdfc Bank Limited | ₹6.9 Cr | Open |
| 31 Dec 2022 | Others | ₹20 Lakh | Open |
| 17 Jan 2024 | Others | ₹6 Cr | Satisfied |
| 21 Jan 2022 | Others | ₹12.75 Cr | Satisfied |
Total charge records: 7 View all charges
Employees and EPFO Compliance at Baader Schulz Laboratories Private Limited
Baader Schulz Laboratories Private Limited has a workforce of 0 employees as of Mar 31, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Baader Schulz Laboratories Private Limited
Baader Schulz Laboratories Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Nailesh Kirtilal Shah was appointed as Director on 29 Jun 2021.
8 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Baader Schulz Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Baader Schulz Laboratories Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Baader Schulz Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Baader Schulz Laboratories Private Limited
Baader Schulz Laboratories has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCB9457E1ZD | Maharashtra | Active | 03 Jan 2022 |
| 26AAJCB9457E1ZF | Daman & Diu | Active | 29 Jun 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Baader Schulz Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Baader Schulz Laboratories Private Limited
Baader Schulz Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 June 2021 (5+ years old) and is registered under CIN U24239MH2021PTC362976.
Baader Schulz Laboratories reported revenue of ₹95.24 Cr for FY 2025 (up 9% YoY).
Baader Schulz Laboratories has 2 current directors:
- Neela Nailesh Shah - Director
- Nailesh Kirtilal Shah - Director
Baader Schulz Laboratories reported a net profit of ₹2.01 Cr (net margin 2.1%) and EBITDA of ₹7.14 Cr (EBITDA margin 7.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Baader Schulz Laboratories is 6% over three years. In the latest year (FY 2025) revenue rose 9%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Baader Schulz Laboratories is 27AAJCB9457E1ZD, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 26AAJCB9457E1ZF (Daman & Diu).
The CIN (Corporate Identification Number) of Baader Schulz Laboratories is U24239MH2021PTC362976. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Baader Schulz Laboratories was incorporated on 29 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Baader Schulz Laboratories by revenue are Ayurvet Limited, Indovax Private Limited, Timo Eva Wellness Private Limited, Natural Herbs and Formulation Private Limited, Provet Pharma Private Limited and 5 more, all in the Pharma industry (Animal Pharma).
Nailesh Kirtilal Shah was appointed as Director on 29 Jun 2021. Neela Nailesh Shah was appointed as Director on 29 Jun 2021.
Baader Schulz Laboratories can be reached through the website baaderschulz.com. Its registered office is in Mumbai, Maharashtra, India.